Timeline

Nathalie Jolly
Head of Facility
15 Mar 2023
project

CoVariant – Comprendre les déterminants de l’immunité muqueuse et optimiser le diagnostic de l’infection aux variants du SARS-CoV-2

Read more
15 Mar 2023
project

Études nécessitant l’accès aux données du Système National des Données de Santé (SNDS).

Read more
04 Jan 2023
news

PREGASIGN: Signatures de biomarqueurs circulants pour la détection des lésions de prénéoplasie et de cancer gastrique

Read more
01 Sep 2022
publication

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

Read more
07 Feb 2022
project

Ressources for good practices in implementing clinical research and translational research on human samples and data

Read more
01 Jan 2022
publication

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.

Read more
16 Jul 2021
news

Séro-épidémiologie du SARS-CoV-2 (études CORSER)

Read more
01 Apr 2021
publication

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020

Read more
06 Nov 2020
news

Suivi de la persistance de la réponse immunitaire contre le SARS-CoV-2 au sein de la cohorte de Crépy-en-Valois (COVID-Oise)

Read more
02 Sep 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Read more
01 Sep 2020
publication

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Read more
26 Jun 2020
news

Curie-O-SA : étude de la réponse immunitaire contre le virus SARS-CoV2

Read more
25 Jun 2018
project

Institut Pasteur’s commitments for clinical trials

Read more
21 Jul 2015
team

Clinical Research Coordination Office

Read more
09 Jan 2009
publication

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial

Read more
03 Dec 2007
publication

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers

Read more
01 Aug 2003
publication

Increased production of interferon-gamma by Leishmania homologue of the mammalian receptor for activated C kinase-reactive CD4+ T cells among human blood mononuclear cells: an early marker of exposure to Leishmania?

Read more